BioLineRx Ltd. (NASDAQ:BLRX) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2023 Financial Results Conference Call.
Source: insidermonkey.com
Mark Breidenbach News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Breidenbach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Breidenbach Today - Breaking & Trending Today
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Syros Pharmaceuticals' First Quarter 2023 Financial Results Conference Call. [Operator Instructions].
Source: insidermonkey.com
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Agios' First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end.
Source: insidermonkey.com
FDA Approves Treatment for Deadly C. Difficile Infections
The FDA on Wednesday approved Seres Therapeutics's pill for treating a type of bacterial infection, giving an easier and standardized option to patients who often have to rely on individual donors for fecal transplants.
Source: medscape.com
Gamida Cell Ltd. (NASDAQ:GMDA) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Gamida Cell's Conference Call for the Full Year 2022 Financial Results.
Source: insidermonkey.com